The appearance of full or double chins can now be successfully improved through non-surgical procedures. One of the most exciting recent innovation in aesthetics is BELKYRA™ treatment, an injectable drug for addressing “submental adipose tissue” (fat) under the chin.
A double chin is a very common condition that can be connected to genetics, aging and/or weight gain. Unfortunately, this fat can be persistent and difficult to lose despite weight loss and lifestyle changes.
BELKYRA™ injections can redefine the jawline by reducing, and potentially eliminating, submental fat without resorting to the invasiveness and recovery needed by surgery.
How Does BELKYRA™ Treatment Work?
BELKYRA™ treatment consists of deoxycholic acid, which aids in the breakdown and absorption of dietary fat.
The formulation is gently inserted into the fat beneath your chin in multiple places. Once injected, BELKYRA™ treatment causes the destruction of fat cells in the targeted area so that they can no longer accumulate or store fat.
What to Expect
Visible results are seen gradually over two to four treatments, providing natural-looking results. The total number of treatments needed will vary by individual, and can be determined upon consultation with a BELKYRA™ injection trained and qualified medical professional.
Temporary side effects may include bruising, numbness or swelling around the treatment area.
BELKYRA™ treatment was approved in 2015 by Health Canada and the FDA (under the label “KYBELLA”). Before approval, BELKYRA™ treatment was supported by over 20 clinical studies worldwide involving over 2,600 patients.
Leaders in BELKYRA™ Injection
Pacific Dermaesthetics was one of the first clinics in Canada to first offer this advanced treatment for lower facial contouring. Regarded as a highly experienced injector and educator, Dr. Rivers is regularly invited to train Canadian physicians on the injection technique for BELKYRA™.
Contact us to book your consultation to learn more about BELKYRA™ injections.
BELKYRA™ is a trademark of Kythera Biopharmaceuticals, Inc., an Allergan affiliate, used under license by Actavis Specialty Pharmaceuticals Co.
- Provides greater chin definition without surgery
- Gradual, natural-looking results
- Minimal downtime after treatment